Intanza® 15 μg Intradermal Seasonal Influenza Vaccine: In Older Adults (Aged ≥60 Years)

ISSN： 1170-229X

Source： Drugs & Aging, Vol.27, Iss.7, 2010-07, pp. : 597-605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inactivated Split-Virion Seasonal Influenza Vaccine (Fluarix®): A Review of its Use in the Prevention of Seasonal Influenza in Adults and the Elderly

By Curran Monique P.

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1519-1543

Adis International

Access to resources Recommend Favorite

Live Attenuated Influenza Vaccine (FluMist®; Fluenz™): A Review of its Use in the Prevention of Seasonal Influenza in Children and Adults

By Carter Natalie J. Curran Monique P.

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1591-1622

Adis International

Access to resources Recommend Favorite

Implementing an Influenza Vaccination Programme for Adults Aged ≥65 Years in Poland: A Cost-Effectiveness Analysis

By Brydak Lidia

Clinical Drug Investigation, Vol. 32, Iss. 2, 2012-02 ,pp. : 73-85

Adis International

Access to resources Recommend Favorite

Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older

By Roland Peter S Ryan Matthew W Wall G Michael

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1559-1567

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Tdap 5 Vaccine (Covaxis®) as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis: In Children (Aged ≥4 Years), Adolescents, and Adults†

By Scott Lesley J.

Pediatric Drugs, Vol. 13, Iss. 2, 2011-04 ,pp. : 133-135

Adis International

Access to resources Recommend Favorite